Explore

Trendline Trendline
Bank of America Allocates $250 Million Annually for Employee Weight Loss Drugs

Bank of America Allocates $250 Million Annually for Employee Weight Loss Drugs

Bank of America Allocates $250 Million Annually for Employee Weight Loss Drugs
USA Today USA Today
Bank of America spends $250M yearly on GLP-1s for workers, CEO says

Bank of America spends $250M yearly on GLP-1s for workers, CEO says

Bank of America's CEO said the company spends more than $250 million a year on GLP-1 drugs for employees, calling the growing cost a worthwhile investment.
Trendline Trendline
Novo Nordisk CEO Resets Expectations for Wegovy's Growth Amid Market Competition

Novo Nordisk CEO Resets Expectations for Wegovy's Growth Amid Market Competition

Novo Nordisk CEO Resets Expectations for Wegovy's Growth Amid Market Competition
Trendline Trendline
Bank of America Warns of Extreme Bullish Sentiment in Markets, Advises Caution

Bank of America Warns of Extreme Bullish Sentiment in Markets, Advises Caution

Bank of America Warns of Extreme Bullish Sentiment in Markets, Advises Caution
Reuters Reuters
Morgan Stanley hires BofA's Kweskin to cover diversified industries

Morgan Stanley hires BofA's Kweskin to cover diversified industries

By Sabrina Valle NEW YORK, Aug 7 (Reuters) - Morgan Stanley has hired diversified industries banker Adam Kweskin to join its Global Industrials Investment Banking Group, according to a person familiar with the matter.
Trendline Trendline
Bank of America Allocates $250 Million Annually for Employee GLP-1 Drugs

Bank of America Allocates $250 Million Annually for Employee GLP-1 Drugs

Bank of America Allocates $250 Million Annually for Employee GLP-1 Drugs
Trendline Trendline
Bank of America Invests $250 Million Annually in Employee Health with GLP-1 Drugs

Bank of America Invests $250 Million Annually in Employee Health with GLP-1 Drugs

Bank of America Invests $250 Million Annually in Employee Health with GLP-1 Drugs
Trendline Trendline
Bank of America Invests Over $250 Million in Employee Health with GLP-1 Drugs

Bank of America Invests Over $250 Million in Employee Health with GLP-1 Drugs

Bank of America Invests Over $250 Million in Employee Health with GLP-1 Drugs
Trendline Trendline
Bank of America Invests $250 Million Annually in GLP-1 Drugs for Employee Health Benefits

Bank of America Invests $250 Million Annually in GLP-1 Drugs for Employee Health Benefits

Bank of America Invests $250 Million Annually in GLP-1 Drugs for Employee Health Benefits
Trendline Trendline
Bank of America CEO Warns of Risks in Leveraged Markets Following Hedge Fund Collapse

Bank of America CEO Warns of Risks in Leveraged Markets Following Hedge Fund Collapse

Bank of America CEO Warns of Risks in Leveraged Markets Following Hedge Fund Collapse
TheStreet TheStreet
Novo Nordisk CEO resets expectations for Wegovy's explosive growth

Novo Nordisk CEO resets expectations for Wegovy's explosive growth

I believe that when a stock is down nearly 10% year to date and down 38% over three years, the CEO's job on a quarterly earnings call is not just to report results. It is to rebuild a narrative that investors have lost confidence in. And Novo Nordisk CEO Mike Doustdar is honestly trying that with ...
Trendline Trendline
Bank of America Reports Strong Q2 2026 Earnings Under CEO Brian Moynihan

Bank of America Reports Strong Q2 2026 Earnings Under CEO Brian Moynihan

Bank of America Reports Strong Q2 2026 Earnings Under CEO Brian Moynihan